Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Assets Average (2023 - 2025)

Historic Assets Average for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q3 2025 value amounting to $1.4 billion.

  • Indivior Pharmaceuticals' Assets Average fell 436.81% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 436.81%. This contributed to the annual value of $1.5 billion for FY2024, which is 1284.38% down from last year.
  • As of Q3 2025, Indivior Pharmaceuticals' Assets Average stood at $1.4 billion, which was down 436.81% from $1.4 billion recorded in Q2 2025.
  • Over the past 5 years, Indivior Pharmaceuticals' Assets Average peaked at $1.8 billion during Q4 2023, and registered a low of $1.3 billion during Q1 2025.
  • Moreover, its 3-year median value for Assets Average was $1.5 billion (2024), whereas its average is $1.6 billion.
  • As far as peak fluctuations go, Indivior Pharmaceuticals' Assets Average plummeted by 2299.17% in 2024, and later tumbled by 436.81% in 2025.
  • Over the past 3 years, Indivior Pharmaceuticals' Assets Average (Quarter) stood at $1.8 billion in 2023, then dropped by 22.99% to $1.4 billion in 2024, then increased by 3.17% to $1.4 billion in 2025.
  • Its Assets Average stands at $1.4 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $1.3 billion for Q1 2025.